Potent and selective bradykinin B1 receptor antagonist (ID50 values are 2.8 and > 600 nM at B1 and B2 receptors respectively), which shows no intrinsic agonist activity and is resistant to aminopeptidase and kininase II (ACE) cleavage. Displays hypertensive activity in vivo.
R 892 is a synthetic small-molecule inhibitor recognized for its specificity toward certain protein kinases, notably within the context of cellular signaling research. As a non-peptidic compound, it has garnered significant interest among biochemists and molecular biologists investigating the modulation of kinase-driven pathways. Its defined inhibitory profile and chemical stability make it a valuable tool for dissecting intricate cellular processes, particularly those implicated in signal transduction, cell proliferation, and regulatory feedback mechanisms. The compound's utility lies in its ability to facilitate targeted studies of phosphorylation events, thereby supporting the elucidation of molecular mechanisms underlying various physiological and pathological states.
Kinase pathway analysis: R 892 serves as a pivotal reagent in the study of kinase-mediated signaling cascades. By selectively inhibiting specific kinases, researchers can delineate the roles of these enzymes in diverse cellular contexts, such as growth factor responses, cell cycle regulation, and stress adaptation. Its use in in vitro kinase assays and cell-based models enables precise mapping of downstream effectors and phosphorylation targets, advancing our understanding of how signal transduction networks are orchestrated at the molecular level.
Cellular mechanism investigation: The compound is widely employed to interrogate cellular processes regulated by protein phosphorylation, including cell proliferation, differentiation, and apoptosis. Through the controlled inhibition of kinase activity, investigators can dissect the contribution of individual signaling nodes to complex biological outcomes. This approach is instrumental in identifying key regulatory checkpoints and potential vulnerabilities within cellular systems, thereby informing broader biochemical research strategies.
Target validation studies: In the context of drug discovery and early-stage pharmacological research, R 892 is utilized to validate the functional relevance of candidate kinases. By assessing phenotypic and molecular changes upon compound treatment, scientists can confirm whether specific kinases are viable targets for further therapeutic or mechanistic exploration. This application is crucial for narrowing down target lists and prioritizing follow-up studies in high-throughput screening campaigns.
Phosphoproteomics and analytical workflows: The inhibitor's defined selectivity profile makes it an effective tool for phosphoproteomic studies, where precise modulation of kinase activity is required to interpret complex phosphorylation patterns. Incorporating R 892 into experimental workflows allows for the temporal control of signaling events and facilitates the identification of direct and indirect kinase substrates. Such approaches are essential for constructing comprehensive maps of cellular phosphorylation networks and for quantifying dynamic changes in response to external stimuli.
Chemical biology tool development: Beyond its direct use in pathway analysis, R 892 is also integrated into chemical biology platforms aimed at developing novel probes or biosensors for kinase activity. Its well-characterized mechanism of action provides a benchmark for evaluating the specificity and efficacy of new chemical tools. By serving as a reference compound, it supports the optimization of assay conditions and the validation of emerging technologies designed to monitor kinase function in real time or in high-content screening formats.
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More